#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Malignant glioma Hereditary spastic paraplegia Cervix carcinoma recurrent Cushing's syndrome Dementia Post transplant lymphoproliferative disorder Hepatic cirrhosis Plasma cell myeloma refractory Spinal cord injury Inflammatory myofibroblastic tumour Gastrooesophageal cancer Extra-osseous Ewing's sarcoma Thalassaemia Leukodystrophy Neuroendocrine carcinoma metastatic More trials…

    Learn about Rare Diseases

    Tuberous sclerosis complex – Life with Disease Synovial sarcoma metastatic Amyotrophic lateral sclerosis – Basic Information Cystic fibrosis lung – Diagnostics Pemphigus – Treatment Nephrotic syndrome – Diagnostics Glycogen storage disease type I – Trials in Disease Congenital generalised lipodystrophy Antithrombin III deficiency – Diagnostics Hereditary angioedema More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Acetylsalicylic Acid Ph. Eur. Dotatate Syn321 Deutivacaftor Tirzepatide Isotretinoin Prednisone Vutrisiran Cdr132L Sodium Memantine Hydrochloride Nipocalimab Arachis Hypogaea (762) Decitabine Oxybuprocaine Hydrochloride Lenalidomide ANHYDROUS CALCIUM FOLINATE Dexamfetamine Sulfate Romidepsin Tobevibart Ezabenlimab More therapies…

    Learn about Your Condition

    Postoperative wound infection Vulvar dysplasia Chondrosarcoma Chronic coronary syndrome Breast cancer recurrent Laryngeal cancer stage II Acute cardiac event Laparoscopic surgery Demyelination Appendicitis Inborn error of metabolism Perthes disease Ulcerative keratitis Endometrial adenocarcinoma Arrhythmia supraventricular More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Diagnostics And Consultation Center Convex Ltd.

Diagnostics And Consultation Center Convex Ltd.

Ulitsa Sinanishko Ezero 11a, Sofia, 1680, Bulgaria

Want to learn more about this study or check if you can participate? Contact us.

  • Study of Efavaleukin Alfa to Treat Adults with Moderate to Severe Ulcerative Colitis

    Not recruiting

    2 1
    Investigated Diseases:
    • Colitis ulcerative
    Austria Belgium Bulgaria Czechia Denmark Finland +11

  • Study of Verekitug to improve symptoms in patients with moderate to severe chronic obstructive pulmonary disease (COPD)

    Not recruiting

    2 1
    Investigated Diseases:
    • Chronic obstructive pulmonary disease
    Investigated Drugs:
    • Human Igg1 Kappa Monoclonal Antibody Against Crlf2
    Bulgaria Czechia Germany Hungary Ireland Latvia +5

  • Long-term safety and effectiveness study of verekitug injections in adults with severe asthma who completed the VALIANT trial

    Not recruiting

    2 1
    Investigated Diseases:
    • Asthmatic crisis
    Investigated Drugs:
    • Human Igg1 Kappa Monoclonal Antibody Against Crlf2
    Bulgaria Czechia Germany Italy Poland Spain

  • Study of AZD0780 in patients with high cholesterol and heart disease or risk of heart disease to lower bad cholesterol levels

    Not recruiting

    3 1
    Investigated Diseases:
    • Hypercholesterolaemia
    Bulgaria Czechia Germany Hungary Poland Slovakia +1

  • Study on IMVT-1402 for Patients with Active Cutaneous Lupus Erythematosus

    Not recruiting

    2 1
    Investigated Drugs:
    • IMEROPRUBART
    Bulgaria Germany Greece Poland Spain

  • Study on the Safety and Effectiveness of IPN10200 for Treating Upper Limb Spasticity in Adults After Stroke or Brain Injury

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Muscle spasticity
    Investigated Drugs:
    • Botulinum Toxin Type A – Haemagglutinin Complex
    • Clostridium Botulinum, Neurotoxin Serotype A/B
    Austria Bulgaria Czechia France Germany Hungary +4

  • Study on the Effects of IMVT-1402 for Adults with Difficult-to-Treat Rheumatoid Arthritis

    Not recruiting

    2 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • IMEROPRUBART
    Bulgaria Czechia Germany Hungary Poland Romania +1

  • Study on GSK5784283 for Adults Aged 18-75 with Uncontrolled Asthma

    Not recruiting

    2 1
    Investigated Drugs:
    • GSK5784283
    Bulgaria Czechia Germany Romania Spain

  • Study on the Safety and Effects of NVG-2089 for Patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

    Not recruiting

    2 1 1
    Investigated Drugs:
    • NVG-2089
    Belgium Bulgaria France Italy Poland Spain

  • Title: Study of Sibeprenlimab Treatment for Adults with Sjögren’s Disease Using Subcutaneous Injections

    Not recruiting

    2 1
    Investigated Drugs:
    • Sibeprenlimab
    Bulgaria Germany Greece Poland Romania Spain
Previous Page
1 … 3 4 5 6 7 … 10
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!